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The evolutionary young miR-1290 favors mitotic exit
and differentiation of human neural progenitors
through altering the cell cycle proteins
SV Yelamanchili*,1, B Morsey1, EB Harrison1, DA Rennard1, K Emanuel1, I Thapa2, DR Bastola2 and HS Fox*,1

Regulation of cellular proliferation and differentiation during brain development results from processes requiring several
regulatory networks to function in synchrony. MicroRNAs are part of this regulatory system. Although many microRNAs are
evolutionarily conserved, recent evolution of such regulatory molecules can enable the acquisition of new means of attaining
specialized functions. Here we identify and report the novel expression and functions of a human and higher primate-specific
microRNA, miR-1290, in neurons. Using human fetal-derived neural progenitors, SH-SY5Y neuroblastoma cell line and H9-ESCderived neural progenitors (H9-NPC), we found miR-1290 to be upregulated during neuronal differentiation, using microarray,
northern blotting and qRT-PCR. We then conducted knockdown and overexpression experiments to look at the functional
consequences of perturbed miR-1290 levels. Knockdown of miR-1290 inhibited differentiation and induced proliferation in
differentiated neurons; correspondingly, miR-1290 overexpression in progenitors led to a slowing down of the cell cycle and
differentiation to neuronal phenotypes. Consequently, we identified that crucial cell cycle proteins were aberrantly changed in
expression level. Therefore, we conclude that miR-1290 is required for maintaining neurons in a differentiated state.
Cell Death and Disease (2014) 5, e982; doi:10.1038/cddis.2013.498; published online 9 January 2014
Subject Category: Neuroscience

The brain is a unique and complex structure. Primates,
particularly apes and humans, have brains that are clearly
distinct both morphologically and functionally from the rest
of the animal kingdom. This evolutionary process is accompanied by tightly regulated interplay of cellular and molecular
processes. The molecular events that differ during the
development of higher-order animals remain largely
unknown. An important event in development, the expansion
of neural progenitor reservoirs and their differentiation to
generate specific neuronal subtypes, is under the control of
several extrinsic and intrinsic factors. Recently, small noncoding RNA molecules, microRNAs (miRNAs) have been
shown to play a pivotal role in embryonic development1,2 and
have remained attractive candidates to study properties of
neural stem cells such as neurogenesis and neural fate
commitment.3 Global disruption of miRNAs through ablation
of Dicer in neural stem cells lead to significant defects in
embryonic mouse brain development.4,5 Importantly, certain
miRNAs affect neuronal differentiation via regulation of their
mRNA targets.6–8
The majority of studies on miRNAs and the brain have been
carried out on miRNAs that are conserved during evolution,
and the conservation of miRNA target in the mRNA
30 -untranslated region (UTR) is used as a criterion in
1

assessing potential miRNA actions on a gene.9 Recently, a
number of evolutionarily young miRNAs have been found.10–12
Many of the novel miRNAs discovered in higher species are
differentially expressed in developing tissues, supporting the
notion that miRNAs may have a key role in the evolved
complexity of higher mammals.11 However, the role of these
nonconserved miRNAs is yet not clear, largely because of the
limitations that accompany studying higher organisms and
organs such as the brain. Here we investigated the function of
a higher species miRNA in human neuronal development
through the use of three different model systems. We have
identified miR-1290, found only in great apes (including
humans), as an important regulator of human neuronal
differentiation process by regulating the levels of critical cell
cycle proteins.
Results
Identification and validation of higher species-specific
miR-1290 in neurons. Isolated single cells from aborted
human fetal brains were grown as neurospheres for a week
and then further differentiated into postmitotic neurons in
culture for 21 days in vitro (DIV) (Supplementary Figure 1A).
Positive immunostaining for markers such as Nestin and
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SOX2 as well as PAX6 and Ki67 (Supplementary Figure 1B)
indicated the progenitor identity and proliferative capacity of
the human neural progenitor cells (hNPCs). Upon differentiation, populations enriched for neurons (hNPC-Ns) were
produced. These neuronal cultures expressed markers such
as MAP2, synaptic vesicle marker VGLUT1 and immature
neuronal marker TUC-4. In addition, a minority of cells in
these cultures also expressed the astrocytic marker GFAP
(Supplementary Figure 1C).
To assess alterations in miRNAs, RNA isolated from
hNPCs and hNPC-Ns from three independent donors
was hybridized to Affymetrix miRNA microarray chips
(Santa Clara, CA, USA). Several miRNAs were differentially
expressed (Supplementary Table 1), and the greatest fold
change and significance in hNPC-Ns when compared with
progenitor cells was for miR-1290 (Figure 1a, left panel).
Further validation by quantitative real-time PCR (qRT-PCR)
confirmed a significant increase in miR-1290 expression
(15-fold, Po0.001, n ¼ 3, t-test) in hNPC-Ns compared with
hNPCs (Figure 1a, right panel). To validate this finding we
next performed northern blotting on RNA derived from hNPC
and hNPC-N samples on four independent donors. The
northern blot revealed the expression of the mature form
(B21 nt) in hNPC-N but not in hNPC samples (Figure 1b).
Next, we asked whether miR-1290 expression is associated
with neuronal, as opposed to astrocytic, differentiation. The
hNPCs containing neurospheres were therefore differentiated
to either astrocytes (hNPC-As) or neurons (hNPC-Ns)
(Figure 1c). qRT-PCR from three independent donors
indicated a robust signal from neurons relative to a low
baseline in astrocytes (4100-fold, Po0.001, n ¼ 3, t-test),
indicating that miR-1290 is strongly associated with a
neuronal phenotype.
MiR-1290 is encoded in the first intron of the ALDH4A1
gene in the human genome, and its expression has only been
described in humans. We examined the Multiz sequence
alignment13 of 44 vertebrate genomic sequences to assess
the evolution of miR-1290. Our results indicate that miR-1290
homologs are present in the Haplorhini clade of primates but
not other vertebrates, dating its origin to B87.2 million years
ago14 and that the mature miR-1290 sequence is exclusive to
the subfamily Homininae (the great apes including humans),
dating its origin to 16.5 million years ago14 (Supplementary
Figure 2).
Although several sequencing studies have reported the
identification of mature miR-1290,15–17 we validated its ability
to be expressed experimentally by the introduction of a
31.4 kb fosmid clone containing the ALDH4A1 and MIR1290
genomic region from humans into mouse NIH3T3 cells that
otherwise do not express miR-1290, lacking the sequence in
the genome. The in situ hybridization (ISH) revealed
the expression of miR-1290 in only transfected cells
(Supplementary Figure 3), and qRT-PCR corroborated
expression of miR-1290 in transfected cells but not mocktransfected cells (4100-fold, Po0.001, n ¼ 3, t-test),
confirming its ability to be expressed and processed.
Next, we performed ISH on human fetal (20-week
gestation) and adult brain sections to assess the expression
of miR-1290. ISH on the fetal frontal cortical sections revealed
that miR-1290 expression was highly nuclear. In order to
Cell Death and Disease

eliminate the possibility of false-positive signals that may arise
because of nonspecific binding of the probe to the genomic
DNA in the nucleus, we treated the fetal sections with RNAse
A that completely destroyed both the positive control U6 signal
and miR-1290 from the nucleus, indicating that the signal was
indeed because of RNA and may result from the unprocessed
pri- and pre-forms (Figure 2a, upper panels). In adult human
frontal brain sections, miR-1290 was highly expressed in
cytoplasm rather than in the nucleus, consistent with the
mature form (Figure 2b, lower panels).
The miR-1290 expression in differentiating human
neuronal cells. In order to model neuronal differentiation
in vitro, we then performed a time course analysis of
differentiating primary hNPCs. ISH indicated a steady
increase in miR-1290 during the course of differentiation
along with the neuronal differentiation marker Tuj1 (Figure 3a).
Simultaneously performed qRT-PCR analysis corroborated
with the results, thereby associating increase in miR-1290
expression with neuronal differentiation (Figure 3b, left
panel).
Next, we utilized the neuroblastoma cell line SH-SY5Y that
can be induced to differentiate into neurons in culture to model
the differentiation process. Indeed, such neuronal differentiation of SH-SY5Y cells led to a significant upregulation of miR1290 expression (Figure 3b, right panel).
Finally, we differentiated the H9 human embryonic stem cell
line (H9-hESC)-derived NPCs (H9-NPCs). H9-NPCs were
positive for neural progenitor markers such as Nestin, Sox2
and Pax6, and for proliferative markers such as Mushashi-1
(MUSH-1). They were negative for the embryonic stem cell
marker OCT4, indicating commitment to neural lineage as
well as for postmitotic marker TUC-4 (Supplementary
Figure 4). Upon differentiation to neurons for 7 DIV, these
cells expressed all the neuronal markers examined: MAP2,
NeuN and Tuj-1 (Figure 3c), along with an increase in
miR-1290 expression in phenotypic neurons (Figure 3c,
bottom panels). Furthermore, qRT-PCR revealed a significant
increase in miR-1290 expression in day 7 differentiated
neurons, corroborating with our initial observation in primary
cells (threefold, Po0.001, n ¼ 4, t-test; Figure 3c, right).
These data further ascertain that increased miR-1290
expression is strongly associated with neuronal differentiation
process.
The miR-1290 inhibition in differentiated immature
neurons leads to increased cellular proliferation and
eventually cell death. As postmitotic differentiation process
increased the expression of miR-1290 drastically, we
assessed the effect of inhibition of miR-1290 in such cells.
H9-NPCs were transfected with miR-1290 or negative (Neg)
inhibitors followed by neuronal differentiation as described
previously. Inhibition of miR-1290 during differentiation of
progenitor cells showed a dramatic increase in cellular
proliferation that is indicated by bromodeoxyuridine (BrdU)
labeling as well as Ki67 staining when compared with
controls (Figures 4a and b); the lower proportion of BrdU
or Ki67-positive cells in the negative control cultures might
represent newly born neurons. In addition, we assessed the
proliferative growth by determining the density of cultures
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Figure 1 MiR-1290 is upregulated during neuronal differentiation. (a) Top five miRNAs that were significantly upregulated in neurons. Volcano plot of the miRNA
microarray performed on three independent donors shows an B15-fold (Po0.001, unpaired Student’s t-test) expression of miR-1290 in h-NPCNs when compared with
h-NPCs. Bar graph on the right represents the postvalidation of miR-1290 by qRT-PCR, and results indicate a 15-fold (Po0.001, n ¼ 3) increase in miR-1290 expression in
hNPCNs. (b) Representative northern blot of RNA derived from hNPCs and hNPC-Ns from four individual donors (D1–D4); note that the anti-DIG signals for the mature form
(B21 nt) were only seen after neuronal differentiation (hNPC-N). A prestained small molecular weight miRNA marker (M) was used to monitor RNA size. (c) Double
immunostaining of astrocytic marker GFAP and neuronal marker MAP2 performed on hNPC differentiated astrocytes in culture, bar ¼ 20 mm. Bar graph on the right
represents 104-fold increased expression in miR-1290 in h-NPC-Ns when compared with astrocytes (104-fold, ***Po0.001, n ¼ 3, unpaired Student’s t-test)
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Figure 2 MiR-1290 signal localizes to nucleus in fetal neurons and to cytoplasm in adult neurons. (a) Double immunolabeling (MAP2) in situ hybridization was performed
on human fetal frontal brain sections with CY5-labeled miR-1290 (upper panels) or a positive control U6 (lower panels). In addition, RNAse A treatment on sections before
probe hybridization abolished any signal for both miR-1290 and U6, confirming that nuclear signals seen in fetal sections are not the result of nonspecific probe binding to
genomic DNA. Bar ¼ 20 mm. (b) Double immunolabeling (MAP2) coupled to in situ hybridization (Cy5-labeled miR-1290) on human adult frontal brain sections. MAP2/miR1290 staining is evident in MAP2-positive neurons where staining is mostly in the cytoplasm. Note that RNase A treatment before probe hybridization abolished miR-1290 or
U6 signals from cytoplasm and nucleus respectively. Bar ¼ 20 mm
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grown on numeric grid coverslips and saw a drastic increase
in density after miR-1290 inhibition (Figure 4c). We hypothesized that such miR-1290 inhibition-induced proliferation in
differentiating cells could lead to apoptosis, and therefore
performed terminal deoxynucleotidyl transferase dUTP nick
end labeling (TUNEL) staining. We observed an increase in
TUNEL-positive cells, confirming that inhibiting miR-1290 not
only disrupted the normal differentiation process but also led
to untimely cell death (Figure 4d). To further examine the
effects on cell proliferation, we transfected SH-SY5Y cells
grown in differentiation medium with miR-1290 inhibitor. The
miR-1290 inhibitor-transfected cells divided more rapidly,
forming a cluster or a colony by day 3 followed by increased
proliferation by day 6. On the other hand, the negative control
inhibitor-transfected cell revealed normal differentiation
process (Figure 4e).
Finally, we examined the effect of miR-1290 inhibition in
differentiated primary human neurons. We transfected
neurons in culture at DIV 21 (where the highest peak of
miR-1290 expression was seen) with miR-1290 inhibitor or a
negative control sequence. ISH revealed the loss of miR-1290
in the neurons that were transfected with the miR-1290
inhibitor when compared with the negative control
(Supplementary Figure 5). During 5 days in culture with the
inhibitor, as compared with the no inhibitor and negative
controls, the miR-1290-inhibited cells started to lose their
processes and formed colonies, indicating an increase in
proliferation, as measured by BrdU labeling (Figure 5).
Results from two different neuronal differentiation models
clearly indicate that inhibiting miR-1290 not only disrupted
differentiation, but also increased proliferation, and ultimately
led to apoptotic cell death.
The miR-1290 overexpression in undifferentiated cells
results in slowing down of the cell cycle and induces
neuronal differentiation. Next, we asked whether we could
induce differentiation by overexpressing miR-1290 in neural
progenitor cells. Using a lentiviral vector to overexpress
miR-1290 (and coexpress fluorescent dsRED) in undifferentiated SH-SY5Y cells, cell cycle analysis performed using
flow cytometry revealed a decrease in proliferating cells, with
a higher proportion of cells in G0/G1 (Figure 6a, control
lentivirus 60.17±0.95, miR-1290 lentivirus 83.33±0.67,
Po0.001, n ¼ 6, t-test) and lower proportion of cells in the
S phase as compared with control (Figure 6a, control
lentivirus 22.33±0.80, miR-1290 lentivirus 6.72±0.17,
Po0.001, n ¼ 6, t-test). We further validated this result in
H9-NPCs by transducing them with lentivirus and selecting
cells for puromycin resistance in medium containing growth
factors that induce proliferation. We observed a dramatic
decrease in colony size when transduced with miR-1290
(Figure 6b). We hypothesized that this could be because
of exiting of cells from cell cycle in order to differentiate.
Indeed, miR-1290-transduced H9-NPCs showed evidence of
neuronal differentiation as indicated by Tuj1 staining
(Figure 6c, control lentivirus 9.00±2.65, miR-1290 lentivirus
56.67±2.40, Po0.001, n ¼ 3, t-test). In order to better
characterize the miR-1290-overexpressing H9-NPCs, we
performed more in-depth examination of Tuj1-positive cells
as well as cells expressing an additional neuronal marker

Tuc-4 and the proliferative marker Ki67. The differentiation
marker Tuj1 showed a stronger staining in cells with neuronal
phenotype than the surrounding cells (Figure 7a, see white
arrows). Similarly, miR-1290-overexpressing cells also
stain strongly with postmitotic marker Tuc-4 (Figure 7b).
Furthermore, compared with the cells transduced with the
negative control lentivirus, Ki67 staining was completely lost
in cells that overexpress miR-1290 (Figures 7c and d),
confirming reduced cellular proliferation.
The miR-1290 targets key cell cycle proteins. The
miR-1290 inhibition and overexpression experiments in
different cell systems have confirmed our hypothesis that
miR-1290 not only plays an important role in neural
differentiation, but also that its lowered expression is
necessary to keep the cells in a proliferative stage, a critical
process during development. Therefore, we hypothesized
its role in maintaining cell cycle repression in neurons.
Repression of gene expression by miRNAs is initiated by its
recognition of target sequences, largely in the 30 -UTR of
mRNAs. To determine the potential targets we examined the
30 -UTRs of all mRNA transcripts for complementarity to the
miR-1290 seed region. These gene targets were examined
for enrichment in Gene Ontology categories, and although
many were present in functional categories related to brain
developmental processes including neuron differentiation,
neural fate commitment and neurogenesis, we also saw an
significant enrichment of target genes whose proteins were
involved in the categories of cell cycle, cell cycle arrest, G1/S
transition of mitotic cell cycle and interphase of mitotic cell
cycle (Supplementary Table 1). These targets included
cyclins, cyclin kinases and cyclin kinase inhibitors. The effect
of miR-1290 on cell cycle regulators was then examined by
western blot analysis on samples derived from miR-1290
overexpression in undifferentiated H9-NPCs and miR-1290
inhibition in neuronally differentiated H9-NPCs. The important cyclin kinase inhibitor p27kip1 (p27), which is responsible for cell cycle exit, and its regulatory components CDK5
and p35, which positively regulate the production of p27,
were examined. Results indicate that when miR-1290 is
inhibited, p27 levels are significantly decreased along with
CDK5 and p35, whereas proliferating cell nuclear antigen
(PCNA) increased (Figure 8a), consistent with miR-1290
inhibition leading to proliferation. Conversely, overexpression
of miR-1290 led to increase in p27, CDK5 and p35 levels and
decrease in PCNA (Figure 8b), consistent with mIR-1290
expression leading to increased cell cycle exit. These data
correlate well with our finding that overexpression of
miR-1290 caused decrease in cell number or colony size.
Discussion
The differentiation of multipotent neural progenitors to
neurons involves complex changes in gene expression that
can be driven by transcriptional and post-transcriptional
mechanisms. To learn more about these changes, we
examined miRNAs, key post-transcriptional regulators of
gene expression with effects on neuronal differentiation.
Newly acquired miRNAs in genomes of higher species can
alter the physiological gene balance at specific stages, for
Cell Death and Disease
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example during development.18 Our data are consistent with
these findings. We identified miR-1290, an evolutionary young
miRNA, as an important regulator of neuronal differentiation in
newly born neurons. Inhibition of miR-1290 in differentiated
H9-NPCs and human primary neurons reverted their postmitotic state, and prolonged inhibition of miR-1290 in

differentiated cells led to cellular death. Overexpression of
miR-1290 in undifferentiated cells led to slowing down of cell
cycle in SH-SY5Y cells and led to differentiation to neurons in
H9-NPCs. Furthermore, we showed that important regulators
for cell cycle exit are perturbed such as p27kip1, CDK5 and
p35 during knockdown or overexpression of miR-1290.
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Figure 4 MiR-1290 is required for neuronal differentiation. (a and b) The miR inhibitor (for miR-1290 and control) in green (miR-FAM)-transfected H9-NPCs were placed in
differentiation medium for 5 days and cells were then labeled with BrdU (red, a) and Ki67 (red, b), bar ¼ 20 mm. Right panels represent increase in % of BrdU and Ki67 labeling
in miR-1290-inhibited cells (n ¼ 3). (c) DAPI staining on cells in the presence/absence of miR-1290 and negative control inhibitors showed a drastic increase in the density of
cells (c, bar ¼ 20 mm). Right panel represents increase in the number of DAPI-labeled nuclei in miR-1290-inhibited cells (n ¼ 3). (d) TUNEL staining on inhibitor-transfected
cells at day 7 in culture, bar ¼ 20 mm. Right panel represents % of mean TUNEL-positive cells (n ¼ 3). **Po0.01, ***Po0.001 determined by an unpaired Student’s t-test.
(e) SH-SY5Y cells were differentiated with 10 mM RA followed by 10 ng/ml BDNF in the presence of the miR inhibitor and monitored during days 1, 3 and 6 of differentiation.
Note the increase in density of culture and lack of neurite formations in miR-1290 inhibitor-transfected cells

Figure 3 MiR-1290 is upregulated during differentiation. (a) Differentiated hNPC-derived neurons (hNPC-Ns) from neurosphere stained with differentiation marker Tuj-1
(green, top panels) and double labeled with miR-1290 (pink, bottom panel), bar ¼ 20 mm. (b) Bar graph on the left represents fold increase in miR-1290 during different days of
h-NPC differentiation to neurons. Bar graph on the right represents fold increase in miR-1290 expression in differentiated SH-SY5Y cells. (c) H9-NPC-derived neurons were
stained with neuronal markers, MAP2, NeuN and Tuj-1 (left panel, bar ¼ 50 mm). Lower-most panels represent ISH images (bar ¼ 20 mm) of H9-NPC-derived neurons during
differentiation; particularly, day 7 neurons show localization of miR-1290, not only in cell body and nucleus but also extending into the processes. Bar graph represents fold
increase in miR-1290 in H9-NPC differentiated cells (threefold, Po0.001, n ¼ 4, unpaired Student’s t-test). *Po0.05, **Po0.01, ***Po0.001 determined by one-way
ANOVA for (b)
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Studies have shown that perturbations in evolutionarily
conserved miRNAs can affect crucial aspects of neurogenesis. For example, miR-9 is essential for proliferation and
migration of H9-hESC-derived NPCs,19 and in mouse NPCs,
miR-34a overexpression reduces neuron yield upon differentiation.20 In addition, the combination of three miRNAs
(miR-9*/miR-9 and miR-124) has been shown to induce
conversion of human fibroblasts into neurons.8 However,
although higher-species specific miRNAs have been found in
the brain,10,11,21 their functional relevance has been
addressed only in few studies. For example, the recently
discovered human-specific miR-941 has been identified to
play a critical role in pluripotent stem cell proliferation and in
neurotransmitter release;21 our microarray analysis did not
show a significance change in its expression during differentiation. Another young miRNA, miR-1246 (following
miR-1290, had next highest significant change in our
microarray analysis, upregulated B10-fold during differentiation), can target DYRK1A, a Down syndrome-associated
protein kinase, and inhibit its activity.22 It is interesting to
speculate that these higher miRNAs have specific roles
in brain functions, and the subtle differences in miRNA
sequences are crucial in determining their evolutionary
conservation across species and thus might help us to
understand their specific functional properties.
One of our models, primary cultures of fetal neurons, do not
represent adult mature neurons as seen in adult human brain
Cell Death and Disease

but can represent neurodevelopmental events taking place in
the developing brain. When stained for neuronal markers, the
human fetal-derived primary cultures not only expressed
MAP2 and NeuN but also markers for immature neurons, Tuj1 and Tuc-4. Interestingly, when we compared ISH signals
between adult human brain and fetal brain, miR-1290 signal in
neurons is predominantly seen in cytoplasm and nucleus,
respectively (Figure 2). This nuclear localization of signal is
also seen in neurons differentiated from primary cultures
(Figure 3a). Studies on the neuronal miR-124 also reveal both
cytoplasmic and nuclear localization.23 Evidence suggests
that processing of the inactive precursor miRNA into the
mature, active form by Dicer may be, in part, regulated by
the sequestration of the precursor form, typically in the
nucleus.24,25 Therefore, it is likely that nuclear signal in
immature neurons represents the unprocessed miR-1290 and
becomes more cytoplasmic as neuron matures that is
evidenced in the adult brain sections. Indeed, this is true as
when we analyzed mature miR-1290 levels by qRT-PCR, we
saw a gradual increase during days of differentiation in vitro
(Figure 3a). Furthermore, northern blot revealed presence of
mature miR-1290 in only differentiated cultures. As inhibition
of mir-1290 levels led to increased proliferation of cells and
overexpression of miR-1290 slowed down cell cycle, we
inferred that it has a role in regulating cell cycle. In support of
this, miR-1290 was upregulated in senescent human lung
fibroblasts when compared with proliferating fibroblasts.26
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The cyclin kinase inhibitor p27 is a central regulator for cell
cycle and is vital for neuronal differentiation. Overexpression
of p27 arrests cells in G1,27 whereas its loss leads to an
increase in cell proliferation.28–30 Cyclin-dependent kinase 5
(CDK5) directly phosphorylates p27,31 and is strongly
activated in postmitotic neurons.32 Loss of CDK5 in mature
neurons facilitated the reentry of the neurons into cell
cycle. 33 During neuronal differentiation and migration, a
positive feedback loop exists between CDK5, its activator
p35 and p27.34 Therefore, we speculated changes in these
core cell cycle proteins during inhibition or overexpression
of miR-1290 in cells. Indeed, we saw a significant
upregulation of p27, CDK5 and p35 with miR-1290
inhibition and their downregulation with miR-1290 in
levels, suggesting that the functional changes are
indeed a result of changes in these proteins. Whether
miR-1290 binds directly to or has an indirect effect on these
proteins through targeting other upstream mediators is yet to
be ascertained.
Although we identified several cell cycle-related genes as
putative targets for miR-1290 (Supplementary Table 2), it is
indeed hard to attribute a specific role for miR-1290 in
controlling cell cycle as its targets are very much spread out as
mapped in the KEGG cell cycle pathway (Supplementary
Figure 6). However, it is possible to construct a tenable
working hypothesis (Figure 8c). There is a direct target, SKP2
(S-phase kinase-associated protein 2, E3 ubiquitin protein
ligase), an E3 ubiquitinase that preferentially ubiquitinates
phosphorylated p27 and targets it for degradation, thus
controlling p27 levels.35–37 Hence, inhibition of SKP2 by
miR-1290 binding will lead to increased p27 levels and cell
cycle exit. Furthermore, we also identified cyclin genes such
as cyclin A and E in the cell cycle pathway that are direct
targets of miR-1290 and can therefore have an indirect effect
on p27, CDK5 and p35 levels.
Reactivation of cell cycle genes in neurons has been found
in neurodegenerative diseases such as Alzheimer’s Disease,
Parkinson’s Disease, Amyotrophic Lateral Sclerosis and
Ataxia Telangiectasia, where entry into the cell cycle is
implicated in untimely neuronal death.38,39 Indeed, these
findings highlight the need of cell cycle check in neurons and
show its failure to be detrimental in adult brain. The neuronal
differentiation models used in this study may recapitulate the
differentiation of immature neurons as seen in the developing
brain; interestingly, reentry into the cell cycle in immature
neurons may lead to a quicker onset of apoptotic death than it
does in mature neurons.38 Intriguingly, delay in cell cycle exit
during brain development may underlie the larger brain sizes
and increased number of neurons in autism spectrum
disorders.40 It would be interesting to study the role of
miR-1290 in such disorders.
Our study strongly suggests that miR-1290 can play a role
in mitotic exit during neuronal differentiation by regulating key
cell cycle proteins. Most miRNA studies utilize evolutionarily
conserved molecules that readily enable studies in vivo in
experimentally tractable animals such as rodents. However,
some physiological systems, in particular the brain, have
evolved to quite advanced functions in humans compared
with rodents. The greatly increased cognitive ability of
humans is linked to the enlargement of the frontal cortex,

and humans and the other great apes share this disproportionate enlargement.41 Determining the unique aspects of
brain and neuronal development and differentiation in higher
organisms will be key to uncovering the processes leading to
these structural and functional differences. The combined
and compelling evidence drawn from various model
systems further strengthens our study. These exciting
studies emphasize the need to study human-specific
miRNAs that have specific and central roles in crucial
neuronal developmental process and much more subtler
processes such as the cell cycle.
In summary, miR-1290 plays a crucial role in neuronal
differentiation. Knockdown of mir-1290 increased proliferation
and inhibited differentiation, whereas overexpression slowed
down the cell cycle and initiated differentiation. The strictly
regulated expression patterns of miR-1290 during proliferation and differentiation stages, its expression exclusive to
higher species and its interaction with key cell cycle proteins
offer strong support for future studies further defining its role
in the neuronal fate specification.
Materials and Methods
Cell culture. Human aborted fetal brain tissue (12–16 weeks post
conception), obtained from University of Washington, was handled in full
compliance with the University of Nebraska Medical Center (UNMC) and NIH
ethical guidelines under IRB approval. Derivation and culturing of NPCs and
derived neurons were carried out as described previously.42 Briefly, cortex was
enzymatically (0.25% trypsin) dissociated into a single-cell suspension.
The cells were maintained in Ex-Vivo15 (Biowhittaker-Lonza Walkersville Inc.,
Walkersville, MD, USA) medium supplemented with N2 supplement (Life
Technologies, Carlsbad, CA, USA), bFGF 20 ng/ml (Sigma, St. Louis, MO,
USA), EGF 20 ng/ml (Sigma), LIF 10 ng/ml (Sigma), NSF-1 (Biowhittaker-Lonza
Walkersville Inc.) and 60 ng/ml N-acetylcarnitine (Sigma). After 3–5 days, cells
form clusters/neurospheres of hNPCs, and are further maintained in the above
medium until differentiation.
After 7–10 days in culture, hNPCs were differentiated into neurons or astrocytes,
which was achieved by gentle mechanical dissociation, if needed; Stempro
Accutase (Life Technologies) was used for dissociation. For neurons, dissociated
cells were plated onto poly-D-lysine-coated plates in Neurobasal media
supplemented with B27 (Life Technologies), 0.5 mM L-glutamine, 10 ng/ml BDNF
(Peprotech Inc., Rocky Hill, NJ, USA) and 10 ng/ml NT3 (Peprotech). Neurons were
grown until DIV 14–21; media was half exchanged as needed. For astrocyte
conversion, hNPCs were plated in astrocyte growth media (DMEM, 10% FBS)
for 1 week.
SH-SY5Y cells were differentiated to neuronal-like cells by replacing the media to
growth media containing 10 mM all-trans retinoic acid (Sigma) for 3 days, followed
by 3 days in 50 ng/ml BDNF.
H9-NPCs were obtained from ArunA Biomedical Inc (Athens, GA, USA) and
passaged three times before using them for experiments. H9-NPCs were cultured
on Matrigel (BD Biosciences, Sparks, MD, USA) in the presence of growth media
(ArunA Biomedical) supplemented with 20 ng/ml bFGF. For differentiation, cells
were plated on Matrigel and bFGF was not added to the growth media; instead, we
added 20 ng/ml NT3 and 20 ng/ml BDNF to sustain the differentiated neurons.
Differentiation was typically carried for 7 DIV.
Antibodies and immunofluorescence. Immunofluorescence was
performed on 4% paraformaldehyde (PFA)-fixed cells permeabilized with 0.25%
Tween-20. Primary antibodies were mouse anti-Nestin (Millipore, Billerica, MA,
USA), rabbit anti-Sox2 (Millipore), mouse anti-MAP2 (Covance, Princeton, NJ,
USA), rabbit anti-GFAP (DAKO, Carpinteria, CA, USA), rabbit anti-Mushashi1
(Millipore), rabbit anti-Tuj1 (Millipore), mouse anti-NeuN (Millipore), mouse antiOct4 (Millipore), rabbit anti-Pax6 (Covance), rabbit anti-TUC4 (Millipore), mouse
anti-Vglut1 (Synaptic Systems, Goettingen, Germany), mouse anti-BrdU (SBCT,
Santa Cruz, CA, USA) and rabbit anti-Ki67 (Abcam, Cambridge, MA, USA).
Species-specific Alexa-Fluor-labeled secondary antibodies was used for detection
followed by mounting in Prolong gold anti-fade with DAPI (Life Technologies).
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Proliferation analysis by BrdU staining. BrdU staining was performed
as described before.43 Briefly, BrdU (10 mM) was added to the cells and incubated
for 4 h at 371C and fixed with 4% PFA for 15 min. Next, the fixed cells were
incubated in 2 N HCl with 0.3% Triton X-100 for 30 min followed by 0.1 M boric
acid (pH 8.0) for 10 min and three rinses with PBS before incubation blocking
solution (0.3% Triton X-100, 1% bovine serum albumin and 3% normal goat serum
in PBS) for 1 h. Next, the cells were incubated with a mouse monoclonal anti-BrdU
antibody (1 : 100) in the blocking solution overnight at 41C. After three PBS rinses,
the Alexa Fluor 568 goat anti-mouse secondary antibody (1 : 500) was applied in
blocking solution for 4 h at room temperature. The cells were rinsed in PBS three
times and visualized using a fluorescent microscope and images were taken. Total
number of BrdU-labeled cells was calculated by normalizing the BrdU signals to
the nuclei stain, DAPI. ImageJ software (http://rsb.info.nih.gov/ij/index.html) was used
for counting the cells in a given field.
RNA isolation and microarray. RNA was isolated using Trizol (Life
Technologies). The miRNA microarray was performed on Affymetrix GeneChip
miRNA 2.0 Array. GeneChip miRNA arrays were run by the UNMC microarray
core using the manufacturer’s recommended equipment and protocols. Data were
analyzed using Partek genomics suite (Partek Inc., St. Louis, MO, USA).
Quantitative real-time PCR. TaqMan mature miR assays for hsa-miR-1290
(Applied Biosystems, Carlsbad, CA, USA) was used to quantify according to the
manufacturer’s protocol. U6 snRNA was used as housekeeping control. Reactions
were performed and calculations made as described using the 2  DDCT method.44
miRNA ISH. Brain tissue sections were obtained for normal adult and fetal
brains from BioChain (BioChain Institute, Inc., Hayward, CA, USA). Tissue
sections were deparaffinized and hydrated before citrate treatment (10 mM citrate,
pH 6.39) at 901C for 40 min followed by washes in 1  PBS. Next, sections were
washed in freshly prepared methlyimidazole buffer containing 130 mM
1-methlyimidazole, 300 mM NaCl, pH 8.0, followed by 1-h incubation with 160 mM
EDC (1-ethly-3-(3-dimethlyaminopropyl)) pH 8.0 solution. Tissue culture cells on
coverslips were fixed in 4% PFA, coverslips were incubated overnight with 70%
ethanol and permeabilized using 0.25% Triton-X-100 for 15 min followed by two
washes in 2  SSC. All specimens were then prehybridized in hybridization buffer
(50% formamide, 10 mM Tris-HCl, pH 8.0, 200 mg/ml yeast tRNA, 1  Denhardt’s
solution, 600 mM NaCl, 0.25% SDS, 1 mM EDTA and 10% dextran sulfate) for 1 h
at 371C in a humidified chamber. LNA-modified miR-1290, U6 snRNA and
scrambled miR probes, labeled at both the 50 and 30 ends with digoxigenin
(Exiqon, Vedbaek, Denmark), were diluted to a final concentration of 4 pM, heated
to 651C for 5 min and separately hybridized at 371C overnight. Specimens were
then washed twice in hybridization buffer (without probe) at 371C, followed by
washing three times in 2  SSC and twice in 0.2  SSC at 421C. They were then
blocked with 1% BSA, 3% normal goat serum in 1  PBS for 1 h at room
temperature and incubated with anti-digoxigenin conjugated with horseradish
peroxidase (Roche Applied Science, Indianapolis, IN, USA). The following day,
sections were washed with two PBS washes and signal amplification (for the
in situ, now labeled with horseradish peroxidase) using TSA Cy5 kit (PerkinElmer,
Waltham, MA, USA) according to the manufacturer’s protocol. The slides were
mounted in Prolong gold anti-fade reagent with DAPI (Life Technologies).
Double label in situ/immunofluorescence was performed as previously
described.44,45 In order to examine the potential for false-positive signals arising
because of nonspecific probe hybridization to the nuclear DNA, sections were
treated with RNAse A (100 mg/ml) for 1 h at 371C before the hybridization step.
miRNA northern blotting. Northern blotting for miRNA detection was
performed with minor modifications as described previously.46,47 Briefly, 10 mg of
RNA denatured in Ambion gel loading buffer II (Life technologies) at 751C for 15 min
was loaded and ran on a 15% TBE-Urea gels (Invitrogen, Carlsbad, CA, USA) at

180 V for 1 h. The gel was then transferred onto a nylon membrane using an iBLOT
DNA transfer stack (Invitrogen) as per the manufacturer’s instructions. Subsequently,
the membrane was crosslinked at 1200 kJ using a STRATALINKER (Stratagene,
La Jolla, CA, USA). The membrane was then prehybridized in the prehyb buffer
(Sigma) at 371C for 1 h followed by addition of 1.2 pmol/ml of LNA-modified 50 and 30
DIG-labeled hsa-miR-1290 probe (Exiqon) to the buffer and hybridization overnight at
371C. The next day, the membrane was washed for 5 min with a low stringency wash
buffer (2  SSC, 0.1% SDS) followed by 2  washes for 20 min each with a high
stringency wash buffer (0.5  SSC, 0.1% SDS) and a final wash for 20 min with
ultrahigh stringency wash buffer (0.1  SSC, 0.1% SDS). After the washes, the
membrane was blocked for 1 h with 1  blocking buffer for 1 h followed by incubation
with Anti-DIG AP antibody in a 1 : 20 000 dilution in blocking buffer. Finally, DIG signal
development was carried out using the DIG wash and block buffer set.
Knockdown and overexpression of miR-1290. The LNA-based
miRNA power inhibitors (with or without 50 -FAM label) were purchased from
Exiqon. Undifferentiated SH-SY5Y cells and H9-NPCs were plated on coverslips
or in six-well plates, at 70% confluency, and 25 nM of the unlabeled/FAM-labeled
miR-1290 or the scrambled inhibitor (Negative control) was transfected using
XtremeGENE-siRNA (Roche Applied Science) as per the manufacturer’s
instructions. The cells were differentiated in the presence of the inhibitor. At the
end of 6 days (for SH-SY5Y) and 5 days (H9-NPCs), coverslips were placed in 4%
PFA for staining and cells on plates were harvested in Trizol for RNA extraction.
Cells transfected with FAM-labeled probes were monitored daily for phenotypic
changes. For knockdown experiments on human neurons derived from primary
fetal cells (hNPC-Ns), neurons were grown in culture for 21 days until fully
differentiated and then transfected with inhibitor as described above. Coverslips
were fixed in 4% PFA at the end of 5 days for analysis.
For overexpression studies, the undifferentiated SH-SY5Ys or H9-NPCs were
transduced with lentivirus expressing miR-1290 (Biosettia, San Diego, CA, USA)
and were maintained in proliferative growth media.
Western blotting. Whole-cell lysates were prepared using RIPA buffer
(50 mM Tris/HCl, pH 8; 150 mM NaCl; 1% Nonidet P-40; 0.5% sodium
deoxycholate; and 0.1% SDS) and protein quantification was carried out using
Pierce BCA protein assay (Thermo Scientific, Rockford, IL, USA). Protein (5–
15 mg) was loaded in each lane of NuPAGE 4–12% Bis-Tris gels (Invitrogen).
Separated proteins were transferred onto nitrocellulose membranes using iBlot
(Invitrogen). The membranes were blocked in SuperBlock (TBS) blocking buffer
(Thermo Scientific) and then incubated overnight at 41C with primary antibody.
The following primary antibodies were used: rabbit polyclonal p27kip1 (1 : 500,
Abcam), rabbit polyclonal p35 (1 : 500, SBCT), mouse monoclonal CDK5 (1 : 1000,
Millipore), mouse monoclonal PCNA (1 : 1000, DAKO) and rabbit polyclonal actin
(1 : 5000; Sigma-Aldrich, St. Louis, MO, USA). This was followed by incubation
with secondary antibody, HRP conjugated anti-rabbit IgG (1 : 20 000; Thermo
Scientific) and anti-mouse IgG (1 : 20 000; Thermo Scientific) for 1 h at room
temperature. Blots were developed using SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific), imaged and quantified using Carestream MI
software (Carestream Health INC, Rochester, NY, USA).
Preparation of miR-1290-expressing lentivirus. The miR-1290expressing lentiviral vector (pLV-miR-1290) and the packaging mix (LTR-pack-1
and LTR-pack-2) were purchased from Biosettia and viral preparations were done
as per the instructions. Briefly, human embryonic kidney (HEK) 293T cells were
transfected with pLV-miR1290, LTR-pack-1 and LTR-pack-2 using XtremeGene
HP transfection reagent (Roche Applied Science) according to the manufacturer’s
protocol. Cell supernatant containing virions was collect 48 and 72 h after
transfection, and concentrated by ultracentrifugation. pLV vector without insert was
used as control. Lentivirus titer was determined using HIV p24 ELISA assay
(Express Biotech International, Thurmont, MD, USA).

Figure 6 MiR-1290 overexpression leads to slowdown of cell cycle in SH-SY5Y cells, reduces the colony formation and induces differentiation in H9-NPCs.
(a) Flow cytometry histograms on the right reveal that SH-SY5Y cells transduced with a lentivirus construct expressing miR-1290 show an increased proportion in G0/G1
phase and a lower proportion in the S phase (bottom), representing the slowing down of cell proliferation (n ¼ 3). (b) H9-NPCs were transduced with a lentivirus
construct expressing miR-1290 or a negative control sequence. Transduced cells selected with puromycin show a drastic decrease in colony size and cell number in
miR-1290-transduced cells when compared with negative (Neg.) control, bar ¼ 50 mm. (c) Immunostaining the colonies with differentiation marker, Tuj-1, showed increased
staining in miR-1290-transduced cells, bar ¼ 20 mm. Bar graph represents increase in % of Tuj1-positive labeling in miR-1290-overexpressed H9-NPCs (n ¼ 3). ***Po0.001
determined by unpaired Student’s t-test
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SH-SY5Y cells or H9-NPCs were grown in vitro till they achieve 80% confluency
and transduced with miR-1290 or control lentivirus at a concentration of 5  106
lentiviral particles/ml. Successful transduction was confirmed by visualizing dsRED
expression. At 5 days after transduction, cells were visualized in Zeiss Observer.Z1
microscope equipped with Axiocam MRm camera using Axiovision 40 v.4.8.0.0
software (CarlZeiss, Oberkochen, Germany).

Proliferation assay. Numeric grid-marked coverslips (Bellco Biotechnology,
Vineland, NJ, USA) coated with Matrigel were used to track proliferation. The
numbers on the grid were used to identify the grid squares that had equivalent cell
densities before transfections. In order to verify the proliferation of H9-NPCs, cells
were plated at a low density (20 000 cells/coverslip) and transfected with FAMlabeled miR-1290 or negative control inhibitors (Exiqon). Cells were differentiated
for 5 days post transfection and fixed in 4% PFA. Each square with equivalent
number of cells was imaged for nuclei stain DAPI. Images were then exported to
ImageJ software for further analysis. The number of DAPI-stained nuclei from
negative control inhibitor and Mir-1290 inhibitor-transfected squares (n ¼ 4) were
normalized to no inhibitor control and the values were represented as percentages
in the bar graphs.
Bioinformatics. The mRNA transcripts were extracted from ENSEMBL. The
miR-1290 gene targets were filtered by mir-1290 seed region (50 -AAAUCCA-30 )
complementarity in the 30 -UTR. To identify the biological networks or pathways,
the FatiGO tool in the Babelomics suite (http://babelomics.bioinfo.cipf.es/) was
utilized.48 FatiGO uses Fisher’s exact test to check for significant overrepresented
GO terms in a group of genes.
Transfection of fosmid DNA. NIH3T3 cells were grown in glass coverslips
or six-well plates and transfected with fosmid clone (G248P89639D9, http://
bacpac.chori.org) by Fugene-HD (Roche Applied Sciences) as per the
manufacturer’s instructions. After 48 h of transfection, coverslips were fixed with
4% PFA and wells harvested for RNA.
Flow cytometry for cell cycle analysis. Cells were stained with Hoechst
stain, assessed by flow cytometry and cell cycle was measured as described
previously.49
TUNEL staining. TUNEL staining was performed as described previously.50
Briefly, ApopTag Plus Peroxidase In situ Apoptosis Detection kit (Millipore) was
used according to the manufacturer’s instructions with minor modifications. Cells
were fixed on coverslips with 1% paraformaldehyde, followed by washes and
postfixation for 5 min at  201C with ethanol/acetic acid (2 : 1), followed by PBS
washes. Samples were reacted for 5 min with 3% H2O2 in PBS to deplete
endogenous peroxidase activity and then washed with PBS. Slides were next
prehybridized in equilibration buffer for 5 min, followed by hybridization with
terminal deoxynucleotidyl transferase enzyme for 1 h at 371C. The hybridization
reaction was terminated by incubation with stop buffer and PBS wash. HRPconjugated anti-digoxigenin was added next (30 min at RT), followed by PBS
wash. The signal was converted to fluorescence using TSA Cy5 kit (PerkinElmer)
according to the manufacturer’s protocol. Coverslips were mounted in Prolong
gold anti-fade reagent with DAPI (Invitrogen).
Statistical analysis. Statistical analysis was performed using GraphPad
Prism software (La Jolla, CA, USA). Student’s t-test or one-way ANOVA followed
by Dunnett’s multiple comparison tests were performed and the P-value was
calculated for each experiment. For all experiments with error bars, S.D. was
calculated to indicate the variation between experiments.
Data deposition accession numbers: The microarray data have been deposited
in NCBI’s gene expression omnibus (GEO) accession number GSE34016
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi).

Figure 7 MiR-1290 overexpression in H9-NPCs leads to the expression of
differentiation markers and proliferative arrest. (a and b) H9-NPCs were transduced
with a lentivirus construct expressing miR-1290 and a negative control sequence.
Immunostaining on transduced cells with differentiation marker Tuj-1 and postmitotic
marker Tuc 4 shows increased expression in miR-1290 cells, indicating that miR-1290
drives differentiation of proliferating cells, bar ¼ 10 mm. (c) Immunostaining on
transduced cells with proliferation marker, Ki67, reveals that miR-1290-expressing cells
stain negative for Ki67, indicating the loss of proliferative capacity when compared with
negative controls (Neg. Control), bar ¼ 10 mm. (d) The miR-1290-transduced
H9-NPCs coexpress the differentiation markers TUC4 and Tuj1, whereas the Neg.
control-transduced cells only show coexpression with proliferation marker Ki67.
Postimage processing was done for DAPI (Blue) channel in Adobe Photoshop as the
signal was weak during capture. Data are represented as % of total DAPI þ cells
under each condition
Cell Death and Disease

Regulation of neuronal differentiation by miR-1290
SV Yelamanchili et al

13

Figure 8 Mir-1290 affects cell cycle proteins. (a) H9-NPCs were differentiated in the presence of miR inhibitors: Neg. Control (NC inhib) or miR-1290 (1290 inhib). Western
blots were run on the protein lysates and probed for p27kip1, CDK5, p35 and PCNA; actin was used as an internal control. Note the decrease in the levels of cell cycle proteins
in the presence of miR-1290 inhibitor. Bar graphs on the right represent statistical analysis for the protein levels normalized to the internal control, actin. (b) H9-NPCs were
transfected with plasmids overexpressing a Neg. Control or miR-1290 sequence for overexpression. Western blots were run on the protein lysates and probed for p27kip1,
CDK5, p35 and PCNA; actin was used as an internal control. Note the increase in the levels of cell cycle proteins during miR-1290 overexpression. Bar graphs on the right
represent statistical analysis for the protein levels normalized to the internal control, actin. *Po0.05, **Po0.01, ***Po0.001 determined by unpaired Student’s t-test. (c)
Schematic representation of a neural progenitor cell and its cell cycle dynamics involving core cell cycle regulators, specifically combinations of CDK/cyclin heterodimers
allowing the progression of cell cycle. Proteins belonging to the Ink family; p15 Ink-4b, p18 Ink-4c and p19 Ink-4d, and Cip/Kip family: p27kip1, p21cip1 and p57kip2, of CDKs
promote cell cycle withdrawal by blocking the activity of cyclins. Proteins in blue represent miR-1290 targets in the core cell cycle regulation. A dual function of miR-1290 is
represented in the working hypothesis on the right. MiR-1290 can target and therefore inhibit the expression of SKP2, an E3 ubiquitinase ligase, thereby increasing p27kip1
levels in the cell favoring mitotic cell exit, or can indirectly effect the levels of p27kip1 by binding to cyclin A and cyclin E (CCNA and CCNE) and therefore inhibit cell cycle
progression
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